Serina Therapeutics (SER) Return on Equity (2019 - 2025)
Historic Return on Equity for Serina Therapeutics (SER) over the last 7 years, with Q3 2025 value amounting to 13.14%.
- Serina Therapeutics' Return on Equity fell 139300.0% to 13.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.14%, marking a year-over-year decrease of 139300.0%. This contributed to the annual value of 1.11% for FY2024, which is 9600.0% up from last year.
- Latest data reveals that Serina Therapeutics reported Return on Equity of 13.14% as of Q3 2025, which was down 139300.0% from 12.75% recorded in Q2 2025.
- In the past 5 years, Serina Therapeutics' Return on Equity registered a high of 2.67% during Q4 2024, and its lowest value of 17.87% during Q1 2025.
- Moreover, its 5-year median value for Return on Equity was 0.26% (2023), whereas its average is 1.89%.
- Its Return on Equity has fluctuated over the past 5 years, first surged by 100800bps in 2021, then tumbled by -181500bps in 2025.
- Over the past 5 years, Serina Therapeutics' Return on Equity (Quarter) stood at 0.01% in 2021, then surged by 6776bps to 0.65% in 2022, then crashed by -81bps to 0.12% in 2023, then surged by 2119bps to 2.67% in 2024, then crashed by -593bps to 13.14% in 2025.
- Its Return on Equity was 13.14% in Q3 2025, compared to 12.75% in Q2 2025 and 17.87% in Q1 2025.